Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide
Shannon R. McCurdy(Johns Hopkins Hospital), Mary Eapen(Medical College of Wisconsin), Maxim Norkin(University of Florida Health), Mehdi Hamadani(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Edmund K. Waller(Emory University), Álvaro Urbano-Ispizúa(Universitat de Barcelona), Asad Bashey, Monzr M. Al Malki(Johns Hopkins Hospital), Daniel A. Keesler(Medical College of Wisconsin), Rizwan Romee(Harvard University), Ephraim J. Fuchs(Johns Hopkins Hospital), Sameh Gaballa(Johns Hopkins Hospital), Miguel‐Angel Perales(Memorial Sloan Kettering Cancer Center), Andrew St. Martin(Johns Hopkins Hospital), Ran Reshef(Abramson Cancer Center), Melhem Solh(Johns Hopkins Hospital), Mei-Jie Zhang(Johns Hopkins Hospital), Vanderson Rocha(Université Paris Cité)
Cited by 96
Related Papers
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.1k
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
|Science Translational Medicine|2016|916
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation
|Blood|2014|880
<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|New England Journal of Medicine|2016|783